SPDR Series Trust SPDR S&P Biotech ETF
לונג
מעודכן

Opening (IRA): XBI January 17th 92 Covered Call

44
... for a 90.47 debit.

Comments: IVR/IV isn't fantastic here at 11.1/26.3%, but there is some IV skew to take advantage of on the call side -- 31.34% at the 92 call relative to 26.62% at the 92 put.

Selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put to take advantage of the IV skew and the built-in defense of the short call. From a charting standpoint, the break even sets up nicely with the "RFK, Jr. low" in November.

Metrics:

Buying Power Effect/Break Even: 90.47
Max Profit: 1.53
ROC at Max: 1.69%
50% Max: .77
ROC at 50% Max: .85
הערה
Rolling, rolling, rolling ... . Down and out from the Jan 17th 92 to the Feb 21st 90 for a 2.94 credit; 87.83 break even.
הערה
Rolling down and out from the Feb 21st 90 to the March 21st 89 for a 1.73 credit; 86.10 break even.
העסקה בוטלה באופן ידני
Taking the opportunity to close out my most "at risk" setup for a small profit. Out for an 86.65 credit; .55 ($55) profit. Still have the March 21st 86's on.

כתב ויתור

המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.